Aflac Incorporated (AFL) Stock

NYSE
FinancialsInsurance - Life Website

AFL has an Alpha Score of 66 out of 100 (moderate), computed on Nov 3, 2026 from 3 of 4 sub-scores. 15 members of Congress disclosed 26 trades in AFL since 2014: 15 purchases and 11 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 6 of the hedge funds AlphaScala tracks reported AFL in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Renaissance Technologies's at $69.56M. Company insiders reported 0 open-market buys and 91 sales on SEC Form 4 in the 90 days to Nov 6, 2026. Its trailing P/E ratio is 12.7 and its net margin 26.9% (key statistics as of Oct 30, 2026).

$124.06
-1.73%
Last price
Source: Finnhub
Alpha Score
66
Moderate

What is AFL's Alpha Score?

How it works →

Alpha Score of 66 reflects moderate overall profile with strong momentum, moderate value, strong quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum
78
Strong
Value
61
Moderate
Quality
79
Strong

Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.

Computed Nov 3, 2026

A rules-based research rating, not a recommendation to buy or sell.

Which members of Congress traded Aflac Incorporated (AFL)?

Members
15
Disclosed trades
26
Purchases
15
Sales
11

Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start Jul 7, 2014.

PoliticianTrade dateTypeAmount
Alan Armstrong
R-OK · Senate
2026-03-27purchase$1k – $15k
Shelley Moore Capito
R-WV · Senate
2025-07-18partial sale$1k – $15k
Carol Miller
R-WV · House
2025-03-10purchase$1k – $15k
Shelley Moore Capito
R-WV · Senate
2025-01-17partial sale$1k – $15k
Marjorie Taylor Greene
R-GA · House
2022-02-22purchase$1k – $15k
John Rutherford
R-FL · House
2022-02-17sale$1k – $15k
Sara Jacobs
D-CA · House
2021-04-09sale$50k – $100k
David Perdue
R-GA · Senate
2020-04-16sale$1k – $15k

From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026. Senate records here end Oct 21, 2026; later Senate trades are not included.

See all AFL political trades →

Which hedge funds own AFL?

From 13F filings
FundShares HeldPosition ValueChange vs prior Q
Renaissance Technologies
Jim Simons (founder)
593K$69.56M-11%
Millennium Management
Israel Englander
537K$62.93M+32%
Citadel
Ken Griffin
329K$38.61M-66%
D.E. Shaw
David Shaw
264K$30.90M+157%
Marshall Wace218K$25.55M-71%
Bridgewater Associates
Ray Dalio
2K$290.3K-96%

13F holdings as of Jun 30, 2026

Explore all tracked funds →

Are Aflac Incorporated insiders buying or selling?

SEC Form 4 filings
90 days to Nov 6, 2026
Buys
0
Sells
91
Net $
-$90.8M
Unique insiders
3
DateInsiderRoleTypeSharesValue
Oct 15, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL88.1K$10.4M
Oct 15, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL19.1K$2.3M
Oct 15, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL6.4K$767K
Oct 14, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL6.3K$735K
Oct 14, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL19.0K$2.2M
Oct 14, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL29.6K$3.5M
Oct 13, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL41.7K$4.8M
Oct 13, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL340$40K
Oct 12, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL11.5K$1.3M
Oct 12, 26Japan Post Holdings Co., Ltd.10%+ OwnerSELL732$85K

SEC Form 4 filings as of Nov 6, 2026

See cluster-buy signals across all tickers →

What are AFL's key statistics?

P/E Ratio
12.68
EPS (TTM)
9.33
Dividend Yield
2.41%
Beta
0.57
Net Margin
26.89%
ROE
16.42%
Debt / Equity
0.28
52W High
$130.22
52W Low
$105.43

Key statistics as of Oct 30, 2026

How does AFL's valuation compare with the Financials sector?

MetricAFLFinancials medianCompanies in median
P/E ratio12.712.8224
Net margin26.89%20.42%210
Return on equity16.42%12.33%236
Dividend yield (payers)2.41%3.33%176

Medians over the Financials stocks whose key statistics were refreshed in the last 35 days (newest Nov 7, 2026). P/E excludes loss-making companies.

What moved AFL recently?

AI-written from the data on this page

Aflac hits 52W high territory as EPS growth, margins drive Alpha Score to 65.9

Aflac shares rose 1.02% to $125.30 on Wednesday, within 4% of the $130.22 52-week high set earlier this year. The stock trades at 12.68 times trailing earnings, below the broader Financials sector median, while net margin of 26.9% and EPS growth of 111% year-over-year stand well above peer averages. Revenue rose 13.6% in the latest period. The Alpha Score of 65.9 reflects strong momentum (78.3) and quality (78.9) sub-scores, though sentiment was not computed in the latest update. The next catalyst is the quarterly earnings report, due before the end of November.

AFL price chart

Powered by TradingView

What does Aflac Incorporated do?

Aflac Inc. is a leading supplemental health and life insurance provider operating primarily in the United States and Japan. The company offers a diverse range of products designed to cover out-of-pocket expenses not typically addressed by primary health plans, including cancer insurance, accident coverage, critical illness policies, disability insurance, dental and vision plans, hospital indemnity, long-term care, medical, nursing care, whole life, and child endowment insurance. Aflac Inc. structures its operations into two key segments: Aflac Japan, which generates the majority of revenue through individual medical and cancer policies distributed via door-to-door sales forces, banks, and financial institutions; and Aflac U.S., focusing on individual and employer-sponsored group policies sold through independent agents, brokers, payroll deduction systems, and digital channels. This dual-market presence enables broad accessibility to consumers at workplaces and beyond, complementing existing coverage for accidents, illnesses, and hospital stays. Founded in 1955 and headquartered in Columbus, Georgia, Aflac Inc. plays a vital role in the global insurance landscape by emphasizing supplemental protection tailored to personal and professional needs.

CEO
Mr. Daniel Paul Amos
Employees
12,716
Market Cap
$61.67B
Ask about AFLAI research agent